Eastman Chemical (EMN) Fundamental Analysis: Revenue, Earnings & Valuation

6.49 / 10

Outperform

Fundamentally, EMN rates Outperform with a 6.5/10 health score. Net‑income‑to‑revenue and cost‑of‑sales ratios are favorable, while cash‑up and operating cash‑flow growth lag. Most key ratios (current, equity multiplier) are bullish, supporting a constructive base.

Analysis Checks(6/10)

Net cash flow from operating activities per share (YoY growth rate %)

Value-23.96

Score0/3

Weight-1.22%

1M Return-0.52%

Equity multiplier

Value2.49

Score3/3

Weight16.30%

1M Return5.48%

Profit-MV

Value1.13

Score2/3

Weight14.27%

1M Return4.34%

Net income-Revenue

Value-0.70

Score2/3

Weight10.98%

1M Return3.54%

Net cash flow from operating activities (YoY growth rate %)

Value-24.63

Score0/3

Weight-0.48%

1M Return-0.21%

Cash-UP

Value0.14

Score1/3

Weight-0.84%

1M Return-0.35%

Long-term debt to working capital ratio (%)

Value6.21

Score1/3

Weight3.38%

1M Return1.22%

Cost of sales ratio (%)

Value78.93

Score3/3

Weight18.86%

1M Return6.54%

Equity multiplier (DuPont analysis %)

Value2.56

Score3/3

Weight19.59%

1M Return6.64%

Current ratio

Value1.37

Score3/3

Weight19.18%

1M Return6.27%

Is EMN fundamentally strong?

EMN scores 6.49/10 on fundamentals and holds a Discounted valuation at present. Backed by its 7.97% ROE, 5.43% net margin, 17.22 P/E ratio, 1.35 P/B ratio, and -46.58% earnings growth, these metrics solidify its Outperform investment rating.